PL2968269T3 - Sposób przygotowywania agonistów beta-3 i produktów pośrednich - Google Patents
Sposób przygotowywania agonistów beta-3 i produktów pośrednichInfo
- Publication number
- PL2968269T3 PL2968269T3 PL14768236T PL14768236T PL2968269T3 PL 2968269 T3 PL2968269 T3 PL 2968269T3 PL 14768236 T PL14768236 T PL 14768236T PL 14768236 T PL14768236 T PL 14768236T PL 2968269 T3 PL2968269 T3 PL 2968269T3
- Authority
- PL
- Poland
- Prior art keywords
- agonists
- intermediates
- preparing beta
- beta
- preparing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
- C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
- C07C215/30—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/10—Nitrogen as only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrrole Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361791247P | 2013-03-15 | 2013-03-15 | |
| PCT/US2014/023858 WO2014150639A1 (en) | 2013-03-15 | 2014-03-12 | Process for preparing beta 3 agonists and intermediates |
| EP14768236.3A EP2968269B1 (en) | 2013-03-15 | 2014-03-12 | Process for preparing beta 3 agonists and intermediates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2968269T3 true PL2968269T3 (pl) | 2020-03-31 |
Family
ID=51580798
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14768236T PL2968269T3 (pl) | 2013-03-15 | 2014-03-12 | Sposób przygotowywania agonistów beta-3 i produktów pośrednich |
Country Status (16)
| Country | Link |
|---|---|
| US (7) | US10287289B2 (pl) |
| EP (2) | EP3597737A1 (pl) |
| JP (1) | JP6383403B2 (pl) |
| CY (1) | CY1122690T1 (pl) |
| DK (1) | DK2968269T3 (pl) |
| ES (1) | ES2746801T3 (pl) |
| HR (1) | HRP20191546T1 (pl) |
| HU (1) | HUE045260T2 (pl) |
| LT (1) | LT2968269T (pl) |
| ME (1) | ME03506B (pl) |
| PL (1) | PL2968269T3 (pl) |
| PT (1) | PT2968269T (pl) |
| RS (1) | RS59402B1 (pl) |
| SI (1) | SI2968269T1 (pl) |
| SM (1) | SMT201900508T1 (pl) |
| WO (1) | WO2014150639A1 (pl) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013062878A1 (en) | 2011-10-27 | 2013-05-02 | Merck Sharp & Dohme Corp. | Process for making beta 3 angonists and intermediates |
| JP6063948B2 (ja) | 2011-10-27 | 2017-01-18 | メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. | ベータ3アゴニストおよび中間体を製造するプロセス |
| LT2968269T (lt) * | 2013-03-15 | 2019-10-25 | Merck Sharp & Dohme | Beta 3 agonistų ir tarpinių junginių gamybos būdas |
| CN104496875B (zh) * | 2014-12-12 | 2017-09-08 | 常州大学 | 2‑烯丙基‑2‑甲醛基‑n‑苯基吡咯碄的合成方法 |
| KR20200012939A (ko) | 2017-06-06 | 2020-02-05 | 유로반트 사이언시즈 게엠베하 | 과민성 방광의 치료를 위한 비베그론의 투약 |
| EP4410295A3 (en) | 2017-06-06 | 2024-10-16 | Urovant Sciences GmbH | Use of vibegron to treat overactive bladder |
| GB201714734D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| CA3098536A1 (en) | 2018-05-23 | 2019-11-28 | Urovant Sciences Gmbh | Use of vibegron to treat pain associated with irritable bowel syndrome |
| NZ774649A (en) | 2018-12-05 | 2025-07-25 | Urovant Sciences Gmbh | Vibegron for the treatment of overactive bladder symptoms |
| EP3941473A1 (en) | 2019-03-18 | 2022-01-26 | Urovant Sciences GmbH | Use of vibegron to treat overactive bladder |
| GB201903832D0 (en) | 2019-03-20 | 2019-05-01 | Atrogi Ab | New compounds and methods |
| WO2022137178A1 (en) | 2020-12-22 | 2022-06-30 | Urovant Sciences Gmbh | Methods of monitoring digoxin with concomitant use of vibegron to treat overactive bladder |
| TW202245781A (zh) | 2021-02-16 | 2022-12-01 | 瑞士商優洛凡特科學公司 | 用維貝格龍(vibegron)治療心臟衰竭之方法 |
| CN113816917B (zh) * | 2021-11-19 | 2022-02-18 | 奥锐特药业(天津)有限公司 | 一种维贝格龙中间体的制备方法 |
| CN115850286B (zh) * | 2022-12-05 | 2023-08-22 | 奥锐特药业(天津)有限公司 | 一种维贝格龙中间体及其制备方法 |
| CN117467628B (zh) * | 2023-09-18 | 2024-04-16 | 长兴制药股份有限公司 | 一种酮还原酶及其制备高光学纯度β-3肾上腺素能激动剂中间体的方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6525202B2 (en) | 2000-07-17 | 2003-02-25 | Wyeth | Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| DOP2003000587A (es) | 2002-02-27 | 2003-08-30 | Pfizer Prod Inc | AGONISTAS DEL RECEPTOR ß3-ADRENERGICO |
| FR2874011B1 (fr) | 2004-08-03 | 2007-06-15 | Sanofi Synthelabo | Derives de sulfonamides, leur preparation et leur application en therapeutique |
| CN101855342B (zh) | 2007-09-13 | 2013-07-10 | 科德克希思公司 | 用于还原苯乙酮的酮还原酶多肽 |
| PE20091825A1 (es) | 2008-04-04 | 2009-12-04 | Merck & Co Inc | Hidroximetil pirrolidinas como agonistas del receptor adrenergico beta 3 |
| EP2329014B1 (en) * | 2008-08-29 | 2014-10-22 | Codexis, Inc. | Ketoreductase polypeptides for the stereoselective production of (4s)-3[(5s)-5(4-fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one |
| IN2012DN02782A (pl) | 2009-10-07 | 2015-09-18 | Merck Sharp & Dohme | |
| US8748433B2 (en) * | 2010-04-30 | 2014-06-10 | Merck Sharp & Dohme Corp. | β3 adrenergic receptor agonists |
| JP6063948B2 (ja) | 2011-10-27 | 2017-01-18 | メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. | ベータ3アゴニストおよび中間体を製造するプロセス |
| WO2013062878A1 (en) | 2011-10-27 | 2013-05-02 | Merck Sharp & Dohme Corp. | Process for making beta 3 angonists and intermediates |
| CN104053771B (zh) * | 2011-11-18 | 2016-11-09 | 科德克希思公司 | 用于制备羟基取代的氨基甲酸酯的生物催化剂 |
| LT2968269T (lt) | 2013-03-15 | 2019-10-25 | Merck Sharp & Dohme | Beta 3 agonistų ir tarpinių junginių gamybos būdas |
-
2014
- 2014-03-12 LT LT14768236T patent/LT2968269T/lt unknown
- 2014-03-12 SI SI201431333T patent/SI2968269T1/sl unknown
- 2014-03-12 JP JP2016501364A patent/JP6383403B2/ja active Active
- 2014-03-12 ME MEP-2019-255A patent/ME03506B/me unknown
- 2014-03-12 US US14/776,366 patent/US10287289B2/en active Active
- 2014-03-12 SM SM20190508T patent/SMT201900508T1/it unknown
- 2014-03-12 EP EP19184972.8A patent/EP3597737A1/en active Pending
- 2014-03-12 DK DK14768236.3T patent/DK2968269T3/da active
- 2014-03-12 WO PCT/US2014/023858 patent/WO2014150639A1/en not_active Ceased
- 2014-03-12 PL PL14768236T patent/PL2968269T3/pl unknown
- 2014-03-12 HR HRP20191546 patent/HRP20191546T1/hr unknown
- 2014-03-12 ES ES14768236T patent/ES2746801T3/es active Active
- 2014-03-12 RS RSP20191136 patent/RS59402B1/sr unknown
- 2014-03-12 EP EP14768236.3A patent/EP2968269B1/en active Active
- 2014-03-12 PT PT147682363T patent/PT2968269T/pt unknown
- 2014-03-12 HU HUE14768236A patent/HUE045260T2/hu unknown
-
2019
- 2019-03-11 US US16/298,467 patent/US10696681B2/en active Active
- 2019-10-09 CY CY20191101059T patent/CY1122690T1/el unknown
-
2020
- 2020-06-26 US US16/914,138 patent/US11091493B2/en active Active
-
2021
- 2021-08-11 US US17/399,274 patent/US11649243B2/en active Active
-
2023
- 2023-11-14 US US18/508,594 patent/US20240300955A1/en not_active Abandoned
-
2024
- 2024-04-29 US US18/649,712 patent/US12180219B2/en active Active
- 2024-12-27 US US19/003,660 patent/US20250304588A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20200392141A1 (en) | 2020-12-17 |
| JP2016515117A (ja) | 2016-05-26 |
| HUE045260T2 (hu) | 2019-12-30 |
| SI2968269T1 (sl) | 2019-12-31 |
| US11091493B2 (en) | 2021-08-17 |
| PT2968269T (pt) | 2019-10-08 |
| US10287289B2 (en) | 2019-05-14 |
| SMT201900508T1 (it) | 2019-11-13 |
| WO2014150639A1 (en) | 2014-09-25 |
| EP3597737A1 (en) | 2020-01-22 |
| US11649243B2 (en) | 2023-05-16 |
| US20170145014A1 (en) | 2017-05-25 |
| ME03506B (me) | 2020-04-20 |
| US10696681B2 (en) | 2020-06-30 |
| US20250304588A1 (en) | 2025-10-02 |
| US20220073523A1 (en) | 2022-03-10 |
| EP2968269A1 (en) | 2016-01-20 |
| JP6383403B2 (ja) | 2018-08-29 |
| RS59402B1 (sr) | 2019-11-29 |
| CY1122690T1 (el) | 2021-03-12 |
| EP2968269A4 (en) | 2016-12-28 |
| DK2968269T3 (da) | 2019-10-07 |
| EP2968269B1 (en) | 2019-07-10 |
| US20240300955A1 (en) | 2024-09-12 |
| ES2746801T3 (es) | 2020-03-06 |
| US12180219B2 (en) | 2024-12-31 |
| LT2968269T (lt) | 2019-10-25 |
| US20190194211A1 (en) | 2019-06-27 |
| US20240300960A1 (en) | 2024-09-12 |
| HRP20191546T1 (hr) | 2019-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2968269T3 (pl) | Sposób przygotowywania agonistów beta-3 i produktów pośrednich | |
| IL269227B (en) | Solid forms of treprostinil | |
| HRP20190233T1 (hr) | Postupci i intermedijeri za dobivanje inhibitora jak | |
| IL246002A0 (en) | Novel methods | |
| LT3080100T (lt) | Lizinui specifinės demetilazės-1 inhibitoriai | |
| LT3290407T (lt) | Bromodomeno inhibitoriai | |
| DK3015467T3 (da) | Morpholino-oligonukleotidfremstillingsfremgangsmåde | |
| HRP20170840T1 (hr) | Supstituirani ksantini i metode njihove uporabe | |
| EP2969007A4 (en) | HISTONE DEMETHYLASE INHIBITORS | |
| PL2941442T3 (pl) | Sposób wytwarzania mikrofibrylarnej celulozy | |
| HUE036383T2 (hu) | Bevonási eljárás | |
| DK3010352T3 (da) | Fremgangsmåde til fremstilling af fodertilsætning | |
| PT2953948T (pt) | Antagonistas de integrina fluorada | |
| LT3038654T (lt) | Naujas panaudojimas | |
| LT3007726T (lt) | Tautopatijos gydymo būdai | |
| DK2970235T3 (da) | Nye inhibitorer | |
| DK2943561T3 (da) | Fotobioreaktor | |
| LT3369724T (lt) | Iopamidolio gamybos būdas | |
| BR112015021083A2 (pt) | método | |
| EP2945942A4 (en) | Voriconazole IMMUNOASSAY | |
| FR3001759B1 (fr) | Rouge aubagee de turbomachine | |
| BR112015029076A2 (pt) | método | |
| FI20135341L (fi) | Menetelmä biopolttoaineen valmistamiseksi ja biopolttoaineen käyttö | |
| IL239971A0 (en) | Isometheptene isomer | |
| DK3047028T3 (da) | Fermenteringsfremgangsmåde |